Literature DB >> 27784469

[China faces a challenge of breast cancer prevention and control].

B N Zhang1, W Q Chen2, X Zhang3, Y L Qiao3.   

Abstract

The incidence and mortality of breast cancer is in an increasing trend. In contrast to the global breast cancer situation, the prevention and control is challenging in China. Some suggestions are presented to the project of breast cancer prevention and control in China. Combining the global screening experiences with the epidemiological features of Chinese female breast cancer, aims to improve the population screening and early detection rate. Standardizing clinical diagnosis and treatment practice, aims to increase the efficacy and decrease the mortality. Intervening lifestyle and dietary behaviors, and intends to reduce risk exposure and incidence. Building national breast cancer registry provides preventive strategies. Great efforts should be made to carry out large sample multicenter clinical trails and translational research on the prevention and cotrol of breast cancer coordiated by health care service and science and technology administrations. Breast cancer prevention and control has a long way to go in China.

Entities:  

Mesh:

Year:  2016        PMID: 27784469     DOI: 10.3760/cma.j.issn.0253-3766.2016.10.018

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

Review 1.  Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer.

Authors:  Dan Mao; Lei Feng; Siqi Huang; Shaofan Zhang; Weijun Peng; Sifang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-12       Impact factor: 2.629

2.  Predictive and prognostic value of circulating blood lymphocyte subsets in metastatic breast cancer.

Authors:  Jian Yang; Junnan Xu; Ying E; Tao Sun
Journal:  Cancer Med       Date:  2019-01-10       Impact factor: 4.452

3.  Role of nutritional support for postoperative recovery of respiratory function in patients with primary lung cancer.

Authors:  Jinhong Yang; Qianqian Zhang; Xiaoli Wang
Journal:  Oncol Lett       Date:  2018-08-22       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.